Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine

BACKGROUND: Once-weekly isoniazid and rifapentine for 3 months is a treatment option in persons with human immunodeficiency virus and latent tuberculosis infection. This study aimed to examine pharmacokinetic drug–drug interactions between this regimen and dolutegravir, a first-line antiretroviral m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Brooks, Kristina M, George, Jomy M, Pau, Alice K, Rupert, Adam, Mehaffy, Carolina, De, Prithwiraj, Dobos, Karen M, Kellogg, Anela, McLaughlin, Mary, McManus, Maryellen, Alfaro, Raul M, Hadigan, Colleen, Kovacs, Joseph A, Kumar, Parag
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6248641/
https://ncbi.nlm.nih.gov/pubmed/29415190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy082
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados